Soar BioDynamics Enhances Online Report for Men with Elevated PSA Scores

New features and resources launch on Web site

SAN FRANCISCO, Nov. 2 /PRNewswire/ -- Soar BioDynamics, a San Francisco-based,
personal health analytics company, announced today the availability of its
updated, user-friendly Cancer Probability Report. The report is designed to
give men and their doctors a brief but clear understanding of their likelihood
of progressing prostate cancer and recommended action steps. In addition, the
company's newly enhanced Web site, www.SoarBioDynamics.com, has expanded
information about the PSA debate plus new navigational tools and graphic
illustrations.

Through its 'Dynamic Screening' process, Soar's proprietary analytics
technology helps men with elevated PSA scores and their doctors by providing
users with simple access to a rigorous analysis of a patient's test results
and medical history. This medical data is compared against tens of thousands
of cases that can help the patient and doctor quickly narrow in on a
personalized approach to care.

"Soar BioDynamics brings game-changing evidence-based analysis to help men and
their doctors cut through the controversy and information overload," said CEO
and Chief Scientist Tom Neville, Ph.D. "The Cancer Probability Report is easy
to understand and helps bring context to PSA scores, allowing doctors to apply
best practices that lead to better outcomes."

Other enhanced resources on the Web site include:

-- Elevated PSA? Provides patients concerned about abnormal PSA scores
with
a clear guide to the issues surrounding prostate screening tests. On
the
page, visitors can walk through what an elevated PSA score means, the
problem of overtreatment and how to use Soar BioDynamics Screening
with
doctors.
-- Why Screen? Gives information about the prevalence of prostate cancer
and an overview of the controversies surrounding screening tests.
-- About Soar BioDynamics: Discusses Soar's Dynamic Screening that
synthesizes best practices validated by the latest peer-reviewed
medical
research for more reliable detection.

-- Dynamic Screening: Offers additional resources such as a glossary of
medical terms, frequently asked questions and a page for physicians,
with data points, research and links to leading medical centers using
dynamic screening best practices.

How the Dynamic Screening Process Works
Patients enter their medical information on www.SoarBioDynamics.com and
receive via email their Cancer Probability Report, a personalized analysis
with a cancer probability scenario and recommended action paths. Soar Dynamic
Screening uses research-based mathematical analysis to augment existing
information by trending patients' individual blood test results and other
factors over time and comparing them to those of representative populations.
As a result, Soar Dynamic Screening aids in the identification of early
indications of prostatitis, BPH and cancer. This analysis may be used to
reduce the risk of false positive biopsy results, recurrence of cancer after
initial treatment and discovery of indolent cancer when compared to
conventional screening. Users can now select to receive their Cancer
Probability Report as a short easy-to-read summary or a more detailed
analysis.

About Soar BioDynamics, Ltd.
Soar BioDynamics harnesses the power of advanced mathematical computation to
bring bold new perspective to common medical test results with an easy-to-use
Web-based system. Dynamic Screening for prostate cancer is Soar's first
invention that has been expanded to screening for prostatitis and BPH. Soar's
Cancer Probability Report can help bring context to PSA test results and help
patients and doctors make more enlightened choices about further tests,
referrals or treatments.

For more information regarding Soar BioDynamics, Ltd. or to view a sample
report, please visit http://www.SoarBioDynamics.com.

SOURCE Soar BioDynamics, Ltd.

Brigette Beaudoin, +1-415-486-3234, Brigette.Beaudoin@edelman.com, for Soar
BioDynamics, Ltd.